EQUITY RESEARCH MEMO
Tailored Clinical Research Solutions
Generated 6/22/2026
Executive Summary
Conviction (model self-assessment)65/100
Tailored Clinical Research Solutions (TCR-Solutions) is a UK-based full-service Clinical Research Organisation (CRO) specializing in Phase I-IV clinical trials. Founded in 2020, the company differentiates itself through a site-focused operational model that fosters genuine collaboration with hospital research governance teams. By leveraging deep expertise in hospital governance, TCR-Solutions aims to streamline trial management for biotech, pharmaceutical, academic, and medical device sponsors globally, improving efficiency and quality. Its core value proposition lies in reducing trial delays and costs through close integration with clinical sites, addressing a key pain point in the industry.
Upcoming Catalysts (preview)
- Q2 2026Major pharma partnership for oncology trials55% success
- Q4 2026Expansion into EU market via new office or acquisition40% success
- Q1 2027Launch of AI-driven patient recruitment platform50% success
Locked sections
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)